Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

Essential role for the lectin pathway in collagen antibody-induced arthritis revealed through use of adenovirus programming complement inhibitor MAp44 expression.

Banda NK, Mehta G, Kjaer TR, Takahashi M, Schaack J, Morrison TE, Thiel S, Arend WP, Holers VM.

J Immunol. 2014 Sep 1;193(5):2455-68. doi: 10.4049/jimmunol.1400752. Epub 2014 Jul 28.

2.

Roles of adipocytes and fibroblasts in activation of the alternative pathway of complement in inflammatory arthritis in mice.

Arend WP, Mehta G, Antonioli AH, Takahashi M, Takahashi K, Stahl GL, Holers VM, Banda NK.

J Immunol. 2013 Jun 15;190(12):6423-33. doi: 10.4049/jimmunol.1300580. Epub 2013 May 6.

3.

Essential role of surface-bound complement factor H in controlling immune complex-induced arthritis.

Banda NK, Mehta G, Ferreira VP, Cortes C, Pickering MC, Pangburn MK, Arend WP, Holers VM.

J Immunol. 2013 Apr 1;190(7):3560-9. doi: 10.4049/jimmunol.1203271. Epub 2013 Feb 22.

4.

Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis.

Arend WP, Firestein GS.

Nat Rev Rheumatol. 2012 Oct;8(10):573-86. doi: 10.1038/nrrheum.2012.134. Epub 2012 Aug 21. Review.

PMID:
22907289
5.

Role of C3a receptors, C5a receptors, and complement protein C6 deficiency in collagen antibody-induced arthritis in mice.

Banda NK, Hyatt S, Antonioli AH, White JT, Glogowska M, Takahashi K, Merkel TJ, Stahl GL, Mueller-Ortiz S, Wetsel R, Arend WP, Holers VM.

J Immunol. 2012 Feb 1;188(3):1469-78. doi: 10.4049/jimmunol.1102310. Epub 2011 Dec 28.

6.

Mechanisms of mannose-binding lectin-associated serine proteases-1/3 activation of the alternative pathway of complement.

Banda NK, Takahashi M, Takahashi K, Stahl GL, Hyatt S, Glogowska M, Wiles TA, Endo Y, Fujita T, Holers VM, Arend WP.

Mol Immunol. 2011 Oct;49(1-2):281-9. doi: 10.1016/j.molimm.2011.08.021. Epub 2011 Sep 23.

7.

N-α-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis.

Willis VC, Gizinski AM, Banda NK, Causey CP, Knuckley B, Cordova KN, Luo Y, Levitt B, Glogowska M, Chandra P, Kulik L, Robinson WH, Arend WP, Thompson PR, Holers VM.

J Immunol. 2011 Apr 1;186(7):4396-404. doi: 10.4049/jimmunol.1001620. Epub 2011 Feb 23.

8.

Essential role of complement mannose-binding lectin-associated serine proteases-1/3 in the murine collagen antibody-induced model of inflammatory arthritis.

Banda NK, Takahashi M, Levitt B, Glogowska M, Nicholas J, Takahashi K, Stahl GL, Fujita T, Arend WP, Holers VM.

J Immunol. 2010 Nov 1;185(9):5598-606. doi: 10.4049/jimmunol.1001564. Epub 2010 Sep 24.

9.

Complement activation pathways in murine immune complex-induced arthritis and in C3a and C5a generation in vitro.

Banda NK, Levitt B, Wood AK, Takahashi K, Stahl GL, Holers VM, Arend WP.

Clin Exp Immunol. 2010 Jan;159(1):100-8. doi: 10.1111/j.1365-2249.2009.04035.x. Epub 2009 Oct 19.

10.

Targeted inhibition of the complement alternative pathway with complement receptor 2 and factor H attenuates collagen antibody-induced arthritis in mice.

Banda NK, Levitt B, Glogowska MJ, Thurman JM, Takahashi K, Stahl GL, Tomlinson S, Arend WP, Holers VM.

J Immunol. 2009 Nov 1;183(9):5928-37. doi: 10.4049/jimmunol.0901826. Epub 2009 Oct 14.

11.

Initiation of the alternative pathway of murine complement by immune complexes is dependent on N-glycans in IgG antibodies.

Banda NK, Wood AK, Takahashi K, Levitt B, Rudd PM, Royle L, Abrahams JL, Stahl GL, Holers VM, Arend WP.

Arthritis Rheum. 2008 Oct;58(10):3081-9. doi: 10.1002/art.23865.

12.

IL-1, IL-18, and IL-33 families of cytokines.

Arend WP, Palmer G, Gabay C.

Immunol Rev. 2008 Jun;223:20-38. doi: 10.1111/j.1600-065X.2008.00624.x. Review.

PMID:
18613828
13.

The development of anticytokine therapeutics for rheumatic diseases.

Arend WP, Goldring MB.

Arthritis Rheum. 2008 Feb;58(2 Suppl):S102-9. doi: 10.1002/art.23053. No abstract available.

14.
15.

Anti-dsDNA antibody assay: high specificity and sensitivity with a filtration radioassay in comparison to low specificity with the standard ELISA.

Yu L, Wang J, O'Dell JR, Oates J, Arend WP, Eisenbarth GS.

J Rheumatol. 2007 Apr;34(4):734-9.

PMID:
17407230
16.

Rheumatoid factor seropositivity is inversely associated with oral contraceptive use in women without rheumatoid arthritis.

Bhatia SS, Majka DS, Kittelson JM, Parrish LA, Ferucci ED, Deane KD, Arend WP, Rewers M, Michael Holers V, Norris JM.

Ann Rheum Dis. 2007 Feb;66(2):267-9. Epub 2006 Jul 25.

17.

Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis.

Banda NK, Thurman JM, Kraus D, Wood A, Carroll MC, Arend WP, Holers VM.

J Immunol. 2006 Aug 1;177(3):1904-12.

18.

Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis.

Kuhn KA, Kulik L, Tomooka B, Braschler KJ, Arend WP, Robinson WH, Holers VM.

J Clin Invest. 2006 Apr;116(4):961-73.

19.

Intracellular IL-1 receptor antagonist type 1 inhibits IL-1-induced cytokine production in keratinocytes through binding to the third component of the COP9 signalosome.

Banda NK, Guthridge C, Sheppard D, Cairns KS, Muggli M, Bech-Otschir D, Dubiel W, Arend WP.

J Immunol. 2005 Mar 15;174(6):3608-16.

20.

Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis.

Ferucci ED, Majka DS, Parrish LA, Moroldo MB, Ryan M, Passo M, Thompson SD, Deane KD, Rewers M, Arend WP, Glass DN, Norris JM, Holers VM.

Arthritis Rheum. 2005 Jan;52(1):239-46.

21.
22.

Enhancement of collagen-induced arthritis in mice genetically deficient in extracellular superoxide dismutase.

Ross AD, Banda NK, Muggli M, Arend WP.

Arthritis Rheum. 2004 Nov;50(11):3702-11.

23.

Cytokines in the rheumatic diseases.

Arend WP, Gabay C.

Rheum Dis Clin North Am. 2004 Feb;30(1):41-67, v-vi. Review.

PMID:
15061568
24.

Generation and characterization of mice transgenic for human IL-18-binding protein isoform a.

Fantuzzi G, Banda NK, Guthridge C, Vondracek A, Kim SH, Siegmund B, Azam T, Sennello JA, Dinarello CA, Arend WP.

J Leukoc Biol. 2003 Nov;74(5):889-96. Epub 2003 Aug 11.

PMID:
12960225
25.

Prevention of collagen-induced arthritis in mice transgenic for the complement inhibitor complement receptor 1-related gene/protein y.

Banda NK, Kraus DM, Muggli M, Bendele A, Holers VM, Arend WP.

J Immunol. 2003 Aug 15;171(4):2109-15.

27.

Mice transgenic for intracellular interleukin-1 receptor antagonist type 1 are protected from collagen-induced arthritis.

Palmer G, Talabot-Ayer D, Szalay-Quinodoz I, Maret M, Arend WP, Gabay C.

Eur J Immunol. 2003 Feb;33(2):434-40.

28.

The role of interleukin-1 receptor antagonist in the prevention and treatment of disease.

Arend WP.

Mod Rheumatol. 2003 Mar;13(1):1-6. doi: 10.3109/s101650300000.

PMID:
24387109
29.

Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein.

Banda NK, Vondracek A, Kraus D, Dinarello CA, Kim SH, Bendele A, Senaldi G, Arend WP.

J Immunol. 2003 Feb 15;170(4):2100-5.

30.

Mechanisms of effects of complement inhibition in murine collagen-induced arthritis.

Banda NK, Kraus D, Vondracek A, Huynh LH, Bendele A, Holers VM, Arend WP.

Arthritis Rheum. 2002 Nov;46(11):3065-75.

31.

The mode of action of cytokine inhibitors.

Arend WP.

J Rheumatol Suppl. 2002 Sep;65:16-21. Review.

PMID:
12236617
32.

The balance between IL-1 and IL-1Ra in disease.

Arend WP.

Cytokine Growth Factor Rev. 2002 Aug-Oct;13(4-5):323-40. Review.

PMID:
12220547
33.

Arthritis & Rheumatism in 2000.

Arend WP.

Arthritis Rheum. 2000 Jan;43(1):1-3. No abstract available.

34.

The innate immune system in rheumatoid arthritis.

Arend WP.

Arthritis Rheum. 2001 Oct;44(10):2224-34. Review. No abstract available.

PMID:
11665962
35.

May 2001: 32 year old female with dural mass encircling cervical spinal cord.

McCarthy PJ, Arend WP, Kleinschmidt-DeMasters BK.

Brain Pathol. 2001 Oct;11(4):483-4, 487.

PMID:
11556695
36.
37.

Cytokines and cellular interactions in inflammatory synovitis.

Arend WP.

J Clin Invest. 2001 May;107(9):1081-2. No abstract available.

38.

Physiology of cytokine pathways in rheumatoid arthritis.

Arend WP.

Arthritis Rheum. 2001 Feb;45(1):101-6. Review.

39.

Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis.

Gabay C, Marinova-Mutafchieva L, Williams RO, Gigley JP, Butler DM, Feldmann M, Arend WP.

Arthritis Rheum. 2001 Feb;44(2):451-62.

40.

Production of IL-1 receptor antagonist by hepatocytes is regulated as an acute-phase protein in vivo.

Gabay C, Gigley J, Sipe J, Arend WP, Fantuzzi G.

Eur J Immunol. 2001 Feb;31(2):490-9.

41.

Physiologic role of interleukin-1 receptor antagonist.

Arend WP, Gabay C.

Arthritis Res. 2000;2(4):245-8. Epub 2000 May 19. Review.

42.

Biological role of interleukin 1 receptor antagonist isoforms.

Arend WP, Guthridge CJ.

Ann Rheum Dis. 2000 Nov;59 Suppl 1:i60-4. Review.

43.

Peptidomimetic fluoromethylketone rescues mice from lethal endotoxic shock.

Grobmyer SR, Armstrong RC, Nicholson SC, Gabay C, Arend WP, Potter SH, Melchior M, Fritz LC, Nathan CF.

Mol Med. 1999 Sep;5(9):585-94.

46.

Treatment of rheumatoid arthritis with IL-1 inhibitors.

Gabay C, Arend WP.

Springer Semin Immunopathol. 1998;20(1-2):229-46. Review.

PMID:
9836379
47.

A unified list of acronyms for the rheumatology literature.

Bombardieri S, Caponi L, Arend WP.

Arthritis Rheum. 1998 Nov;41(11):1901-5. No abstract available.

PMID:
9811042
48.

The differential production of three forms of IL-1 receptor antagonist by human neutrophils and monocytes.

Malyak M, Smith MF Jr, Abel AA, Hance KR, Arend WP.

J Immunol. 1998 Aug 15;161(4):2004-10.

49.

Characterization of a low molecular weight isoform of IL-1 receptor antagonist.

Malyak M, Guthridge JM, Hance KR, Dower SK, Freed JH, Arend WP.

J Immunol. 1998 Aug 15;161(4):1997-2003.

50.

Interleukin-1 receptor antagonist: role in biology.

Arend WP, Malyak M, Guthridge CJ, Gabay C.

Annu Rev Immunol. 1998;16:27-55. Review.

PMID:
9597123

Supplemental Content

Loading ...
Support Center